Aeglea raises $50M in IPO after slashing share price

John Carroll Austin, TC-based Aeglea BioTherapeutics raised $ 50 million in its IPO after pricing 5 million shares at $ 10 each, far below the range that it had set out for itself. FierceBiotech ...

China’s CARsgen raises $30M for CAR-T work

John Carroll Shanghai-based CARsgen Therapeutics has rounded up a $ 30 million B round to advance its work on CAR-T therapies. The biotech has been working on personalized CAR-T programs, ...

Soon-Shiong’s NantCell raises another $57M for immuno-oncology work

Damian Garde Billionaire entrepreneur Patrick Soon-Shiong's NantCell raised $ 57.3 million in equity to fund its work on treatments that use the immune system to fight cancer, ...

Syros raises $40M to get its leukemia drug into Phase II

Damian Garde Syros Pharmaceuticals raised $ 40 million in equity to push forward with its pipeline of genetically targeted drugs, securing the cash it needs to take its top prospect ...

Theracos raises $25M to take on Big Pharma in diabetes

Damian Garde Marlborough, MA's Theracos raised $ 25 million to support its work on a safer version of a common treatment for Type 2 diabetes. FierceBiotech News

Cardiorentis raises $60M as PhIII heart failure trial nears completion

Nick Paul Taylor Cardiorentis has raised CHF 60 million ($ 60 million). The investment bolsters the biotech's bank balance at a time when it is nearing the end of a Phase III trial ...

Startup raises $15M to turn an old diabetes drug into a potent cancer killer

Damian Garde A group of scientists at UCLA have cooked up some compounds that could harness the cancer-fighting properties of metformin while avoiding the biological hurdles that have ...

Grifols bags €100M for Alzheimer’s R&D; Ipsen inks $137M cancer deal; Oryzon raises €17M

Nick Paul Taylor In this week's EuroBiotech Report, Catalan biotech Grifols secured a €100 million ($ 110 million) loan from the European Investment Bank's €315 billion ...

Strongbridge raises $25M in a downsized IPO

Damian Garde Drug developer Strongbridge Biopharma cleared $ 25 million in an IPO, bringing in less than a third of the cash it once sought as biotech companies continue to struggle ...

Ex-Pharmacyclics team raises $33.5M for checkpoint drug

John Carroll Ex-Pharmacyclics CEO Richard Miller is looking for a second act in biotech with his startup Corvus Pharmaceuticals. FierceBiotech News

J&J sets up shop at Karolinska Institutet; Lilly, Zealand scrap R&D pact; Mapi raises $10M

Nick Paul Taylor In this week's EuroBiotech Report, Johnson & Johnson added another outpost to its burgeoning network of startup-scouting units. The J&J-Karolinska Institutet ...

Lux Capital raises $350M to expand its startup portfolio

Damian Garde Lux Capital, a New York venture investor, put together a $ 350 million fourth fund, cash that will help bankroll startups in energy, technology and biotech. FierceBiotech ...
Page 1 of 3123
© 2017 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS